Myesha Lacy
Plus aucun poste en cours
Profil
Myesha Lacy worked as a VP of Investor Relations & Corporate Communications at Global Blood Therapeutics, Inc. and Adverum Biotechnologies, Inc. before obtaining an undergraduate degree from Holy Names University.
Anciens postes connus de Myesha Lacy
| Sociétés | Poste | Fin |
|---|---|---|
| GLOBAL BLOOD THERAPEUTICS, INC. | Investor Relations Contact | - |
| ADVERUM BIOTECHNOLOGIES, INC. | Investor Relations Contact | - |
Formation de Myesha Lacy
| Holy Names University | Undergraduate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ADVERUM BIOTECHNOLOGIES, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Global Blood Therapeutics, Inc.
 Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir, and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA. | Health Technology |